Literature DB >> 7604148

5-HT3 agonist-induced dopamine overflow during withdrawal from continuous or intermittent cocaine administration.

G R King1, Z Xue, C Calvi, E H Ellinwood.   

Abstract

This experiment examined alterations in the ability of the highly selective 5-HT3 receptor agonist, 1-(m-chlorophenyl)-biguanide (mCPBG), to induce dopamine (DA) overflow in caudate brain slices obtained from rats withdrawn from continuous or intermittent cocaine administration. Rats were pretreated with 40 mg/kg per day cocaine for 14 days by either subcutaneous injections or osmotic minipumps, and then withdrawn from this regimen for 7 days. Caudate brain slices were obtained, and perfused with artificial cerebrospinal fluid. Following an equilibration period, the slices were then perfused with 25, 50, or 100 microM mCPBG. The samples were assayed for DA content by HPLC with electrochemical detection. The results indicated that the pretreatment with intermittent cocaine did not consistently alter the ability of mCPBG to induce DA overflow, although there was a reduction in the amount of DA released by the highest concentration of mCPBG. In contrast, pretreatment with continuous cocaine administration consistently and significantly attenuated the ability of mCPBG to induce DA overflow. The DA overflow induced by mCPBG was partially dependent on extracellular Ca2+ in the perfusion medium for the saline control and intermittent administration subjects: elimination of Ca2+ from the medium significantly reduced, but did not eliminate, DA overflow for these two groups. In contrast, elimination of Ca2+ from the perfusion medium had a significant enhancing effect on mCPBG-induced DA overflow in the continuous administration rats. These results suggest that distinct temporal patterns of cocaine administration differentially alter the ability of a 5-HT3 agonist to increase extracellular DA levels, and that this effect may be related to an impairment of Ca(2+)-dependent release.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7604148     DOI: 10.1007/BF02246219

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  50 in total

Review 1.  Serotonin receptor "families" in the central nervous system: an overview.

Authors:  S J Peroutka; A W Schmidt; A J Sleight; M A Harrington
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

2.  Chronic oral cocaine self-administration: pharmacokinetics and effects on spontaneous and discriminative motor functions.

Authors:  J L Falk; F Ma; C E Lau
Journal:  J Pharmacol Exp Ther       Date:  1991-04       Impact factor: 4.030

3.  Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens.

Authors:  P W Kalivas; P Duffy
Journal:  Synapse       Date:  1990       Impact factor: 2.562

4.  Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan.

Authors:  M E Carroll; S T Lac; M Asencio; R Kragh
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study.

Authors:  L H Jiang; C R Ashby; R J Kasser; R Y Wang
Journal:  Brain Res       Date:  1990-04-09       Impact factor: 3.252

6.  Technique for the continuous infusion of high doses of cocaine by osmotic minipump.

Authors:  C Joyner; G King; T H Lee; E H Ellinwood
Journal:  Pharmacol Biochem Behav       Date:  1993-04       Impact factor: 3.533

7.  Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.

Authors:  R M Hagan; B J Jones; C C Jordan; M B Tyers
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

8.  Withdrawal from continuous or intermittent cocaine: effects of NAN-190 on cocaine-induced locomotion.

Authors:  G R King; C Joyner; T H Lee; E H Ellinwood
Journal:  Pharmacol Biochem Behav       Date:  1993-02       Impact factor: 3.533

9.  A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.

Authors:  M E Reith; H Sershen; D L Allen; A Lajtha
Journal:  Mol Pharmacol       Date:  1983-05       Impact factor: 4.436

10.  GR38032F, a serotonin 5-HT3 antagonist, fails to alter cocaine self-administration in rats.

Authors:  R Peltier; S Schenk
Journal:  Pharmacol Biochem Behav       Date:  1991-05       Impact factor: 3.533

View more
  3 in total

Review 1.  The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors:  A J Greenshaw; P H Silverstone
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 2.  Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

Authors:  K D Alex; E A Pehek
Journal:  Pharmacol Ther       Date:  2006-10-17       Impact factor: 12.310

Review 3.  The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy.

Authors:  E A Engleman; Z A Rodd; R L Bell; J M Murphy
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.